AMIKACIN (Arikayce Liposomal®)

Clinical Indication

Non-tuberculous mycobacterial (NTM) lung infections


Not yet reviewed

Date of classification

May 2021


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.